Objective: Children with congenital diaphragmatic hernia (CDH) suffer from long-term pulmonary morbidity. Longitudinal data of exercise capacity in these children are lacking. We hypothesized that exercise capacity would be impaired in children with CDH and deteriorates over time. We evaluated exercise capacity and its determinants in CDH patients longitudinally until 12 years of age.
| INTRODUCTION
Congenital diaphragmatic hernia (CDH) occurs in 1 in 3000-4000 births. 1 Although CDH is still a life-threatening anomaly, survival rates have increased over the past decades. 2 Advances in surgical and neonatal management, as well as the implementation of a standardized
European neonatal treatment protocol in November 2007 3 (Table 1 of the online supplement), have significantly contributed to higher survival rates 2 which turned out to be sustainable over time and in many centers around the world. With the increased survival, more children may suffer from long-term morbidities, including pulmonary symptoms. Factors that may contribute to long-term pulmonary morbidity are lung hypoplasia with persistent airflow obstruction, 4,5 iatrogenic lung damage due to mechanical ventilation, 4 and microstructural changes in the lung. 6 These pulmonary abnormalities may lead to decreased exercise capacity on the long-term and affect development in later life.
While several studies found decreased exercise capacity in CDH patients at school-age, [7] [8] [9] [10] [11] a few other studies showed normal exercise capacity in school-aged 5, 12 and in adult CDH patients. 13, 14 These studies had mostly a cross-sectional study design, small sample sizes, and included patients born before a standardized postnatal treatment protocol became available. A longitudinal evaluation of exercise capacity in CDH patients has not been performed to date.
Therefore, the aim of the present study was to evaluate longitudinally exercise capacity at the ages of 5, 8, and 12 years in a large cohort of CDH patients treated with or without neonatal extracorporeal membrane oxygenation (ECMO). Secondarily, we aimed to find clinical determinants of exercise capacity. Furthermore, we evaluated whether the implementation of a standardized postnatal treatment protocol influenced exercise capacity. Ventilator-free days in the first 28 days of life. b Congenital heart disease: Ventricle Septum Defect (n = 1), Atrium Septum Defect (n = 2), Ventricle Septum Defect and Atrium Septum Defect (n = 1), Double
Outlet Right Ventricle + transposition blood vessel + Open Foramen Ovale + Open Ductus Botalli (n = 1), Open Ductus Botalli + Open Foramen Ovale + tricuspidalis and mitral insufficiency (n = 1), Open Ductus Botalli + Atrium Septum Defect with surgery (n = 2), dysplastic pulmonic valve and tricuspidalis insufficiency (n = 1). Data are presented as mean ± standard deviation, median (interquartile range) or number (percentage), as appropriate. ECMO = extracorporeal membrane oxygenation, PDE5 treatment = treatment with phosphodiesterase type 5 inhibitor. 
| Statistical analysis
Differences in baseline data between "participants in the follow-up program" and "non-participants in the follow-up program" and the children "treated with neonatal ECMO" and "not treated with neonatal ECMO" were evaluated using Mann-Whitney U tests for continuous variables and chi-square tests for categorical variables.
One-sample t-tests were used to test whether the normally distributed data of exercise capacity differed from population norms (SDS = 0). To test whether exercise capacity differed between ECMO treated CDH patients and non-ECMO treated CDH patients, independent samples t-tests were used. Longitudinal evaluation of the endurance times at 5, 8, and 12 years of age was performed using linear mixed-models, which can account for within-subject correlations and allows for missing values in the dependent variable. 24 To investigate whether perinatal and demographic characteristics had a significant influence on SDS endurance time,
we considered the following list of baseline data in the linear mixed- after BD (at 8 years of age) were significantly different between these groups (Table 1 ). No differences in background characteristics, except for ethnicity (P = 0.001) and birthweight (P = 0.030), were found between the participants and non-participants of our follow-up program (data not shown).
| Exercise capacity
The estimated marginal mean (95% confidence interval (CI)) SDS endurance time was significantly below the norm at all ages: 5 years: (−1.40 to −0.80) (all P < 0.001) ( Table 3 ). The mean (SD) heart rate at maximal exercise was 191 (9.0) beats per minute and the median (IQR)
transcutaneous oxygen saturation at maximal exercise was 98% (96-99). Exercise capacity decreased significantly from the ages of 5 to 8 years (P < 0.001) and from 5 to 12 years (P < 0.001) ( Table 2 of the online supplement).
3 All VIFs were ≤3.1.
| Exercise capacity estimated by the parents
The levels of exercise capacity as estimated by the parents correlated positively with the measured SDS endurance time (r = 0.420, P < 0.001).
| DISCUSSION
We evaluated longitudinally maximal exercise capacity in children with CDH aged 5 to 12 years. Exercise capacity was significantly below the norm at all ages, and declined significantly over time-not only in children treated with ECMO but also in those who did not need ECMO treatment. The duration of initial hospital stay and the diffusion capacity of the lungs were associated with exercise capacity.
Treatment of neonates with CDH is challenging and therapeutic strategies have changed over the decades. This has resulted in decreasing mortality rates, 2,25 and development of lung protecting strategies, for example, gentle ventilation with permissive hypercapnia. 26 Therefore, it is hard to compare the data of our population with those who survived over 20 years ago. 8,12-14,27, 28 We previously found decreased exercise capacity in 5-year-old CDH patients, irrespective of whether they had been treated with ECMO. 10 In another study, in children with different underlying diagnoses, who had all been treated with neonatal ECMO, we showed that maximal exercise capacity was below the norm at 5, 8, and 12 years and deteriorated over time. 11 Many children in that study cohort were born in the early 1990s. 11 Despite the differences in study population, a similar course in deteriorating of exercise capacity was observed in the current study. These findings suggest that exercise capacity should be assessed in childhood and adolescence, and even into adulthood. The We assumed that children with more severe lung hypoplasia, might be at the highest risk for impaired exercise capacity. Indeed, children who had been treated with ECMO had significantly more airflow obstruction and lower SDS endurance time. Interestingly, K CO was significantly below the norm both in ECMO treated and non-ECMO treated children and was positively associated with exercise capacity, whereas ECMO treatment was not associated with exercise capacity. We speculate that microstructural changes of the lungs, which have been described in young adults with CDH, 6 may already occur at younger age. Future studies focusing on lung structure imaging may be useful to identify patients at risk for clinical deterioration and impaired exercise tolerance. The association between initial hospital stay duration and exercise capacity that we 
After follow-up assessment the patient was referred to a local community based pediatric physical therapist to start intervention. b After follow-up assessment the patient was recommended to continue intervention by a local community based pediatric physical therapist.
Data are presented as median (interquartile range) or number (percentage), as appropriate. ECMO, extracorporeal membrane oxygenation. hypothesized that children born very preterm are deconditioned and that a lack of physical activity might play a role. 31 Although in our study ECMO treatment had no significant influence on decreased exercise capacity and its deterioration, we assume that the lower exercise capacity in ECMO treated CDH patients might be explained by the fact that ECMO treated patients are the most critically ill children at neonatal age with more severe lung hypoplasia, more airflow obstruction, and less participation in physical activities. number of children assessed at 12 years of age increases the probability of a type II error, although mixed models account for data missing at random. Secondly, postnatal management of CDH changed during the study period, which could have influenced our results as more children with severe lung hypoplasia survived after introduction of the standardized postnatal treatment protocol. We did not find a significant effect of the introduction of the postnatal treatment protocol on exercise capacity (Tables 3 and 4 of the online supplement), but larger sample sizes of 8-year-old and 12-year-old children may be needed to detect a significant difference. Thirdly, we used the maximal endurance time rather than the peak oxygen consumption as measure of exercise capacity, mainly for reasons of feasibility. Wearing a mask may lead to loss of cooperation and to submaximal results, especially in the younger children. A strong correlation between maximal endurance time and maximal oxygen uptake has been reported by Cumming and coworkers. 32 Besides, since our setting is an outpatient clinic and not a primary research setting, we feel that cardiopulmonary exercise testing (CPX), which includes breath gas analysis, is too intensive to perform in every CDH patient during routine follow-up. In future research projects in our department, CPX in children will be evaluated, and conclusions on exercise capacity in CDH patients might be extended. Fourthly, we did not include a group of healthy controls. However, we used recently established reference data collected in our own center.
21,22
Fifthly, we had no data on physical activity. Reduced physical activity might be one of the explanations for decreased exercise capacity in children with CDH and is subject of an ongoing research project in for FEV 1 (R 2 = 0.27; P = 0.001). In another study of our research group none of the lung function parameters, but DL CO was related to VO 2 peak % pred. in young adult CDH patients. 14 Therefore, as multicollinearity arose between lung function parameters in this study, we critically chose to include only FEV 1, TLC and K CO in the mixed model analysis.
The significant differences in ethnicity and birthweight between the participants and non-participants in this study was in line with expectations. We found a higher percentage of other ethnicities than Dutch and lower birthweight in the non-participant group. Native Dutch parents and children showed higher follow-up and treatment adherence than parents of other ethnicities. 33 Differences in birthweight between ethnicities are common. 34 Nevertheless, we will pursue our strategies to enhance adherence in non-native Dutch parents and children in our follow-up program. Background characteristics that reflect severity of illness did not differ between the 
| CONCLUSION
CDH patients were at risk for decreased exercise capacity at schoolage. Decreased exercise capacity deteriorated over time, not only in children who had needed neonatal ECMO treatment but also in children who had not needed ECMO. Exercise capacity was significantly negatively associated with the duration of initial hospital stay and positively with K CO . Early risk stratification for decreased exercise capacity may be important to offer timely intervention.
Further studies are needed to unravel the causes of decreased exercise capacity. We recommend prolonged follow-up, pro-active advice on physical activities and sports participation or referral to a physical therapist.
